Aditxt
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Aditxt and other ETFs, options, and stocks.About ADTX
Aditxt, Inc. is a biotech innovation company, which engages in the development and commercialization of technologies focusing on monitoring and modulating the immune system. Its innovation portfolio includes Adimune and AditxtScore.
CEOJeffrey Mark Busch
CEOJeffrey Mark Busch
Employees26
Employees26
HeadquartersMountain View, California
HeadquartersMountain View, California
Founded2017
Founded2017
Employees26
Employees26
ADTX Key Statistics
Market cap8.40K
Market cap8.40K
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume1.13B
Average volume1.13B
High today$0.019
High today$0.019
Low today$0.0068
Low today$0.0068
Open price$0.0155
Open price$0.0155
Volume5.38B
Volume5.38B
52 Week high$53,451.08
52 Week high$53,451.08
52 Week low$0.0041
52 Week low$0.0041
Stock Snapshot
With a market cap of 8.4K, Aditxt(ADTX) trades at $0.01.
On 2026-06-20, Aditxt(ADTX) stock moved within a range of $0.01 to $0.02. With shares now at $0.01, the stock is trading +77.9% above its intraday low and -36.3% below the session's peak.
Trading volume for Aditxt(ADTX) stock has reached 5.38B, versus its average volume of 1.13B.
The stock's 52-week range extends from a low of $0.00 to a high of $53,451.08.
The stock's 52-week range extends from a low of $0.00 to a high of $53,451.08.
ADTX News
Benzinga 2d
Nasdaq Surges 300 Points; US Initial Jobless Claims Edge Lower - Benzinga...
Benzinga 3d
Aditxt Stock Is Falling After Hours: What Is Going On?Aditxt Inc. (NASDAQ:ADTX) shares fell 33.94% in after-hours trading on Tuesday after a new SEC Form 4 filing showed major shareholder HRT Financial LP purchased...
People also own
Based on the portfolios of people who own ADTX. This list is generated using Robinhood data, and it’s not a recommendation.